Dr Sue Pavord is a consultant haematologist in Oxford and Vice President of the British Society for Haematology. Her special areas of interest are immunohaematology, hemostasis, thrombosis, obstetric hematology and iron management.

Dr Pavord has been a key player in the identification of Vaccine-induced immune thrombosis and thrombocytopenia (VITT) as a new syndrome occurring after COVID-19 vaccination. She is chair of the Expert Haematology Panel focused on VITT, which has guided the UK’s prevention and management of this condition, through daily clinical meetings held over 4 months during the surge of cases. With analysis of the cases, communications with the UK regulatory authorities and development of management guidelines with the National Institute for Health and Care Excellence she has helped to reduce morbidity and mortality of this devastating condition.